NCT06006273 2025-11-10A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Recruiting48 enrolled